November 2014

Features

You can now determine whether Sjögren’s syndrome is contributing to your patients’ dry eyes.

New agents are promising, but approvals are likely several years away.

Although these conditions are usually easy to identify, they can sometimes mimic one another.

Experts describe the best ways to incorporate the latest point-of-care dry-eye tests into your ocular surface disease workup.

Devices that help smartphones take high-quality pictures of the eye are getting more portable, less expensive and easier to use.

Optional for now, compliance programs are a part of the ACA. Here are steps to develop a program before they’re mandatory.

After nearly a decade of use, what the data says about the ocular and systemic safety of these increasingly used drugs.

In spite of a growing understanding of its molecular basis, idiopathic orbital inflammatory syndrome is still a challenge.

Statistical analysis of progression can be misleading unless the doctor compensates for changes in the patient’s condition.

Young patients with oculocutaneous albinism can benefit from traditional ophthalmological care and new low-vision devices.

The endothelium can begin to falter from disease, but there are methods in development to help restore it.

A surgeon describes the SATs—surface ablation techniques—that help him get the best outcomes with PRK.

A fleshy mass, initially diagnosed as conjunctivitis, persists despite treatment, and the patient seeks assistance at Wills Eye Hospital.